Acropolis Investment Management »

Aurinia Pharmaceuticals shares owned by Acropolis Investment Management

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Acropolis Investment Management from 13F filings

Historical chart of Acropolis Investment Management investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Acropolis Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Acropolis Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $242k 29k 8.47
2025-06-30 $242k 29k 8.47

More positions owned by Acropolis Investment Management

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Us Sml Cap Eqt (SMLF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Msci Usa Mmentm (MTUM)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Us Large Cap Val (DFLV)

View all positions for Acropolis Investment Management

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Vanguard Group
Geode Capital Management
Marshall Wace
Renaissance Technologies
Two Sigma Investments
Jacobs Levy Equity Management
Jane Street
Qube Research & Technologies
Henderson Group

View all funds holding Aurinia Pharmaceuticals